ArticleAnnals of the New York Academy of Sciences2026
Kidney Tumor Segmentation With a Multistage Adaptive Boundary-Aware Network.
Article in Annals of the New York Academy of Sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Spine-anchored active contour-based renal spatial prioritization for precision-constrained volumetric segmentation of bilateral nephric tumors via spine-guided 3D deep encoders in abdominopelvic tomographic data.Radiological physics and technology · 2026Article
- Frugal Learning Methods for Kidney Segmentation in Non-Contrast MRI.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate kidney tumor segmentation is critical for surgical planning but is challenged by indistinct boundaries and high morphological variability in computed tomography (CT) images. We propose the adaptive boundary-aware network (MABS-Net). The architecture integrates three core innovations: (1) a boundary-aware multiscale feature extraction module using learnable boundary-enhancing convolutions and adaptive weight maps to capture subtle edge cues; (2) an adaptive three-stage cascaded strategy for progressive refinement from coarse localization to uncertainty-driven boundary optimization; and (3) a contrastive learning mechanism with online hard example mining to explicitly boost feature discrimination between tumor and normal tissues in ambiguous regions. Experiments on the KiTS19 and KiTS21 datasets demonstrate MABS-Net's superiority. On KiTS19, it achieved a Dice coefficient of 0.891 ± 0.034, significantly outperforming the nnU-Net baseline. Notably, the 95% Hausdorff distance (HD95) was reduced to 6.73 ± 2.28 mm, and the boundary Dice score improved by 5.8% compared to state-of-the-art methods, validating our boundary-aware design. Furthermore, the model provides pixel-wise uncertainty maps to support reliable clinical decision-making. MABS-Net balances high accuracy with computational efficiency (0.53 s/case), presenting a promising solution for automated renal tumor analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.